• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 A(H1N1) pandemic influenza viruses.

Giuseppe

Emeritus
J Virol. 2009 Dec 30. [Epub ahead of print]

Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 A(H1N1) pandemic influenza viruses.

Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE Jr. - Departments of Pediatrics and of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA; Department of Microbiology, Mount Sinai School of Medicine, New York 10029, USA.


The 2009 A(H1N1) pandemic influenza virus exhibits hemagglutinin protein sequence homology with the 1918 pandemic influenza virus. We found that human monoclonal antibodies recognized the Sa antigenic site on the head domain of both 1918 and 2009 hemagglutinins, a site that is hypervariable due to immune selection. These antibodies exhibited high potency against the 2009 virus in vitro, and one exerted a marked therapeutic effect in vivo.

PMID: 20042511 [PubMed - as supplied by publisher]

-
------
 
Back
Top